Subcutaneous microdialysis in mitochondrial cytopathy

被引:4
作者
Damian, MS [1 ]
Sauter, W [1 ]
Reichmann, H [1 ]
机构
[1] Tech Univ Dresden, Dept Neurol, D-01307 Dresden, Germany
关键词
metabolic monitoring; microdialysis; mitochondrial disease;
D O I
10.1002/mus.1050
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We present the results of subcutaneous microdialysis, a new minimally invasive biochemical monitoring technique, in mitochondrial cytopathy. We studied 6 ambulatory patients with mitochondrial cytopathy and 6 controls without mitochondrial disease using a subcutaneous probe for continuous microdialysis, and obtained measurements of lactate, pyruvate, and glucose from samples gathered at 30-60 min intervals during the day and at 3-h intervals at night, The lactate:pyruvate ratio (LPR) was calculated and related to disease severity and metabolic stress. Microdialysis was well tolerated. Controls had stable lactate and pyruvate values in the normal range and a low LPR (average values between 0.0114 and 0.0145). Patients had widely fluctuating lactate and pyruvate values, a higher average LPR between 0.0187 and 0.0724, and marked diurnal variation, especially in the severely affected patients, Increases in the LPR coincided with metabolic stress in individual cases, We conclude that subcutaneous microdialysis is well tolerated and enables continuous metabolic monitoring of patients with mitochondrial cytopathy. It has particular potential for use in the identification of metabolic risk factors and may help to assess the impact of therapeutic regimens. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:648 / 653
页数:6
相关论文
共 14 条
[1]   MARKED REDUCTION IN CSF LACTATE AND PYRUVATE LEVELS AFTER COQ THERAPY IN A PATIENT WITH MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC-ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) [J].
ABE, K ;
FUJIMURA, H ;
NISHIKAWA, Y ;
YORIFUJI, S ;
MEZAKI, T ;
HIRONO, N ;
NISHITANI, N ;
KAMEYAMA, M .
ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (06) :356-359
[2]   Functional evaluation techniques in mitochondrial disorders [J].
Argov, Z .
EUROPEAN NEUROLOGY, 1998, 39 (02) :65-71
[3]  
Boutelle MG, 1996, ACT NEUR S, V67, P13
[4]  
Chan A, 1998, NERVENARZT, V69, P472, DOI 10.1007/s001150050300
[5]   Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy [J].
Chan, A ;
Reichmann, H ;
Kogel, A ;
Beck, A ;
Gold, R .
JOURNAL OF NEUROLOGY, 1998, 245 (10) :681-685
[6]   STROKE-LIKE EPISODES IN FAMILIAL MITOCHONDRIAL ENCEPHALOMYOPATHY - CLINICAL AND BIOCHEMICAL ASPECTS [J].
DAMIAN, MS ;
REICHMANN, H ;
SCHUTZ, HJ ;
DORNDORF, W ;
SCHACHENMAYR, W .
JOURNAL OF NEUROLOGY, 1991, 238 (02) :83-86
[7]  
Gutierrez A, 1999, EUR J CLIN INVEST, V29, P947
[8]  
HALLER RG, 1990, MYOLOGY, P807
[9]  
HAMMANS SR, 1994, MITOCHONDRIAL DISORD, P49
[10]   Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue [J].
Lafontan, M ;
Arner, P .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (09) :309-313